Harvard Business Review

MAY 20, 2014

In pharmaceuticals, the largest company, Pfizer, is the result of decades of mergers. The current corporate entity is comprised of firms that used to be called: King Pharmaceuticals, Wyeth, American Cyanamid, Lederle, Pharmacia, Upjohn, Searle, SUGEN, Warner-Lambert, Parke-Davis and others. Economy Entrepreneurship Finance'

Pharmaceuticals 10

Pharmaceuticals Banking Chemicals Trends 10

Harvard Business Review

APRIL 2, 2018

There is an abundance of high-quality comparative effectiveness data for pharmaceuticals, largely because of the drug approval process, but there’s less data on the value of other expensive investments into health, such as doctor visits and hospitalizations. (For

Health Care 8

Health Care Insurance Pharmaceuticals Incentives 8

Harvard Business Review

OCTOBER 13, 2011

The pharmaceutical industry also creates products with complex interactions and potentially dangerous side effects. Yet unlike in finance, where distributing risk across institutions is the goal, in drug development the focus is on isolating risk. Here, the protocols from other industries can provide some insight.

Banking 10

Banking Pharmaceuticals Microfinance Risk Management 10

Harvard Business Review

OCTOBER 25, 2018

We focus on economic profit rather than revenue size, market share, or productivity growth because these other metrics risk including firms that are simply large and may not create economic value. Productivity can help; but it is not enough to achieve superstardom.

Industry 12

Industry Company GDP Bottom-up 12

Harvard Business Review

JULY 4, 2017

’ One could imagine an Apple car that is a Tesla-like product—one with comparable speed, self-driving technology, aesthetics, and features–but is so seamlessly integrated with the Apple ecosystem and requires a new sized iPhone, or some kind of blend of iPhone, iPad or MacBook. How about a man cave on wheels? Or a kitchen?

Transportation 9

Transportation Sports Pharmaceuticals Health Care 9

Harvard Business Review

APRIL 19, 2016

Imagine the changes afoot in the pharmaceutical, medical device, automotive, and consumer electronics industries. For example, printing products on demand would significantly reduce the U.S. What happens, for example, if the value of a product’s underlying intellectual property overtakes its production value?

Supply Chain 8

Supply Chain Execution Analysis Technology 8

Harvard Business Review

OCTOBER 20, 2016

Imports among the world’s 20 largest economies have fallen as a share of their gross domestic product for four consecutive years. Meanwhile the Institute of International Finance forecasted net capital flows for emerging markets in 2015 would be negative for the first time since 1988. at the forefront.

Globalization 8

Globalization Banking Policies Politics 8

Harvard Business Review

AUGUST 3, 2012

Their reliance on alliances and licenses has increased in both product development and marketing and they have become aggressive acquirers. They'll become themselves less attractive as partners and licensees and over time they'll gradually become less able to finance acquisitions. As yet, the facts don't seem to substantiate the fears.

Licensing 13

Licensing Depreciation Pharmaceuticals Budgeting 13

Harvard Business Review

JUNE 29, 2015

If you ask someone who works in finance (as I had to) about PE and innovation, he or she will likely tell you that PE sponsors aren’t looking for the next big thing—they’re looking for companies that are dominant in a market, aren’t risky, and have a predictable and steady stream of cash to pay back debt.

LBO 8

LBO Innovation Sample Short-term 8

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces. It’s not just products. Experimentation is vital.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

AUGUST 2, 2011

In reality, each country needs the other to succeed in order to thrive — to finance growth, secure export markets, train talent, transfer technology, and more. For example, pharmaceutical firms license compounds to each other and co-promote products in different markets.

Apparel 15

Apparel Pharmaceuticals Finance Licensing 15

Harvard Business Review

NOVEMBER 9, 2011

COOs are relatively common in service industries such as financial services, energy, information technology and telecommunications, but in manufacturing sectors — such as automotive, chemical, and pharmaceutical companies — they are relatively rare.

COO 12

COO Sample Telecommunications Automotive 12

Harvard Business Review

JUNE 16, 2016

Pharmaceutical companies spend millions upon millions preparing meticulous plans for new drug launches – and yet their route-to-market strategies haven’t changed in decades, even though the reality of the market has. .” Avoiding a $500 million mistake is surely just as valuable as launching a $500 million product.

Planning 8

Planning Competitive Intelligence Pharmaceuticals Brand 8

Harvard Business Review

SEPTEMBER 10, 2013

A good idea faces so many obstacles en route to market today that it''s a wonder we have any innovative products at all. Companies should consider offering rewards for people who solve internal problems or create new products. Finance Innovation' It''s like that. Recognition is a powerful reward too. Ready to Innovate?

Venture Capitalist 8

Venture Capitalist Venture Funding Innovation Incentives 8

Harvard Business Review

SEPTEMBER 5, 2016

Pearson, the educational publisher, measures the efficacy of its products to improve educational outcomes. Cigna is the first insurance company to get pharmaceutical companies to agree to value pricing based on results for certain cholesterol-lowering drugs. ” Health care. ” Health care. Required Capabilities.

Incentives 8

Incentives Health Care Education Insurance 8

Harvard Business Review

SEPTEMBER 10, 2013

A good idea faces so many obstacles en route to market today that it’s a wonder we have any innovative products at all. Companies should consider offering rewards for people who solve internal problems or create new products. Finance Innovation Insight Center_Innovation no-intromercial' It’s like that. Get a Lawyer.

Venture Capitalist 8

Venture Capitalist Venture Funding Innovation Incentives 8

Harvard Business Review

APRIL 5, 2012

This allowed the business to grow sales productivity by 7 percent and give back a budgeted $2 million for additional headcount — the productivity improvements allowed the sales organization to meet growth goals without adding people. GE also used the information to redeploy several sales territories into more lucrative markets.

Retail 9

Retail Incentives Tactics Pharmaceuticals 9

Harvard Business Review

AUGUST 23, 2012

For highly regulated sectors like finance, social media can be a legal minefield. These hurdles aren't unique to financial services — insurance, pharmaceuticals, health care and government all face regulation, to name a few examples. "Follow us here for updates on our work, our research, and our people.".

Compliance 15

Compliance Media Compliance Officer Policies 15

Harvard Business Review

MAY 1, 2013

Without adequate financing, ministries of health and even private hospitals in developing countries often don''t have the resources needed to purchase diagnostic equipment, train workers, and ensure access to appropriate treatment. Three people die every minute from tuberculosis — a treatable and largely preventable disease.

Health Care 8

Health Care ROI NGO Long-term 8

Harvard Business Review

SEPTEMBER 21, 2015

Terry, a highly regarded marketing associate in a pharmaceutical firm, had just been asked to lead a marketing team. They just weren’t putting together a high-quality product. This way, any information her team needed from finance, sales, or any other department would arrive on time and in the specified format.

Management 8

Management Pharmaceuticals Learning-by-Doing Marketing 8

Harvard Business Review

MAY 5, 2016

The country’s urbanized and large middle class has maintained a strong preference for foreign-made products despite restrictions due to U.S. There are some exemptions for humanitarian-designated sectors, such as agriculture, food products, health care, and civil aviation.). sanctions are delaying these projects being financed.

Tourism 8

Tourism Banking Due Diligence Hotels 8

Harvard Business Review

SEPTEMBER 13, 2011

Here are some common examples: When pharmaceutical companies announce that a new drug has been "approved," they are actually saying that their researchers made some breakthrough discoveries as far back as fifteen years ago.

Short-term 14

Short-term Pharmaceuticals Long-term Maturity 14

Harvard Business Review

FEBRUARY 20, 2014

But an awful lot of these jobs command very high-wages in law, finance, accounting, consulting, advertising, engineering, design, software, healthcare, scientific research, architecture, entertainment, hospitality, and many other areas. Since then, America’s productivity lead has been growing sharply, not falling behind.

Intellectual Capital 8

Intellectual Capital Magazine Pharmaceuticals Creativity 8

Harvard Business Review

FEBRUARY 26, 2013

But when leaders take this conservative growth approach even when there is reasonable certainty of success and available financing, they undersize their sales forces and forfeit opportunity. Split a Territory as Soon as Its Sales Hit a Threshold Level.

Company 8

Company Short-term Long-term Cost 8

Harvard Business Review

MAY 15, 2013

In large part, culture is a product of compensation." — Alec Haverstick. Are patterns of behavior the product of incentives, or have incentives been shaped in fundamental ways by beliefs and values that underpin the culture? finance vs. marketing) and units (e.g. Culture is powerfully shaped by incentives.

Incentives 8

Incentives Definition Pharmaceuticals System 8

Harvard Business Review

FEBRUARY 24, 2015

These preparatory steps are of particular importance for carve-outs that are not full-fledged business units with profit & loss responsibility, such as R&D centers or production units whose only customer is their parent. The outsiders provide new blood in support functions such as finance, legal, or administration.

Chemicals 8

Chemicals How To Kahneman Reputation 8

Harvard Business Review

FEBRUARY 4, 2013

Levi Strauss, intriguingly, has used biomimetic techniques in developing new production techniques for jeans. Perhaps surprisingly, two leading examples come from pharmaceutical companies. Breakthrough Finance. Breakthrough Activism. Breakthrough Access. Breakthrough involves a shift to new types of impact investment.

EPS 8

EPS Innovation CEO Pharmaceuticals 8

Harvard Business Review

OCTOBER 24, 2014

Here are some of the challenges that I’ve observed: Product management. Successful IoT plays require more than simply adding connectivity to a product and charging for service — something many companies don’t immediately understand. When product-based companies add services and connectivity, operational requirements increase.

Productivity 8

Productivity Products Company Engineering 8

Harvard Business Review

APRIL 23, 2012

Supreme Court is expected to rule on whether the work done by pharmaceutical salespeople really counts as "selling." pharmaceutical industry could face billions in retroactive overtime. By any reasonable definition, pharmaceutical salespeople are absolutely salespeople. SmithKline Beecham Corp. By June, the U.S.

Pharmaceuticals 13

Pharmaceuticals Banking Objective Incentives 13

Harvard Business Review

SEPTEMBER 4, 2015

However, CEOs often don’t have the career background and education that would equip them to personally lead the process of new product development. We found that, for pharmaceutical industry CEOs, there is a statistically significant relationship between a CEO’s specialist background and the firm’s performance.

CEO 8

CEO Innovation Pharmaceuticals Merchandising 8

Harvard Business Review

JANUARY 10, 2013

initiative — prohibitions against off-label marketing under the False Claims Act — swept through the pharmaceutical industry. The most notable was Fannie Mae's $10.8 billion restatement. In another instance, a new enforcement. The largest payments were from Pfizer ($2.3 billion) and GlaxoSmithKline ($3 billion).

Finance 8

Finance Banking Press Release Pharmaceuticals 8

Harvard Business Review

NOVEMBER 20, 2015

One result is that they keep their cards close to their chests about what they are looking for (at first), while expecting you to reveal everything – your finances, pricing, ownership, human resources, production processes, quality assurance, customer service procedures, KPIs, and existing customers.

Supply Chain 8

Supply Chain Collins Golden Handcuff Pharmaceuticals 8

Harvard Business Review

JANUARY 26, 2016

and European corporations, from CI-trained analysts in marketing, business development, strategy, R&D, finance, and other fields. The analyst was involved in product launches. Perhaps the analysts involved with product launches are thus given more of a mandate than analysts involved in other kinds of activities.

Competitive Intelligence 8

Competitive Intelligence Company CAPEX Analysis 8

Harvard Business Review

MARCH 6, 2014

Indeed, should this have not crossed your mind, the PLoS authors tie their findings to past behavior by the tobacco and pharmaceutical industries. Imagine a product with a 100 percent failure rate. But we consume information just like any other product; we take flight on the reliability of data.

Peer Review 8

Peer Review Review Industry Wilde 8

Harvard Business Review

JUNE 20, 2017

For example, a key source of concern for some companies is more-restrictive rules of origin, which would reduce the amount of materials allowed to be used tariff-free for products traded to and from NAFTA member countries. So, if a company manufactures products in Mexico to export to Canada and the U.S.

Supply Chain 8

Supply Chain Depreciation Uncertainty Marketing 8

Harvard Business Review

JANUARY 4, 2017

There are similar stories in the electronics industry, pet food, pharmaceuticals, and even national security. This regulation came as a result of concerns that the exploitation and trade of conflict minerals by armed groups was helping to finance conflict in the DRC region and contributing to its emergency humanitarian crisis.

Supply Chain 9

Supply Chain Productivity Products Company 9

Harvard Business Review

AUGUST 23, 2016

Both Republicans and Democrats say the most effective board committee is audit/finance. food, beverage & tobacco, household and personal products); Energy & Utilities (e.g., pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g.,

Politics 8

Politics Committee Telecommunications Diversity 8